GABAA receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats

Life Sciences

Volumn 84, Issue 5-6, 2009, Pages 156-163

  Meena, Harsahay ^a   Nakhate, Kartik T ^a   Kokare, Dadasaheb M ^a   Subhedar, Nishikant K ^b  

^a RTM NAGPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Antipsychotics; Body weight; Food intake; GABAA receptors; Nucleus accumbens shell

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; DIAZEPAM; HALOPERIDOL; MUSCIMOL; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; WEIGHT GAIN; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; GABA ANTAGONISTS; HALOPERIDOL; HYPERPHAGIA; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; WEIGHT GAIN;

EID: 58249120876     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.11.013     Document Type: Article

References (70)

1. Alcantara A.A., Chen V., Herring B.E., Mendenhall J.M., and Berlanga M.L. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Research 986 1-2 (2003) 22-29
2. Allison D.B., Mentore J.L., Heo M., Chandler L.P., Cappelleri J.C., Infante M.S., and Weiden P.J. Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 156 11 (1999) 1686-1696
3. Alvarez-Jiménez M., González-Blanch C., Crespo-Facorro B., Hetrick S., Rodríguez-Sánchez J.M., Pérez-Iglesias R., and Vázquez-Barquero J.L. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs 22 7 (2008) 547-562
4. Baldo B.A., Sadeghian K., Basso A.M., and Kelley A.E. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on ingestive behavior and associated motor activity. Behavioral Brain Research 137 1-2 (2002) 165-177
5. Baldo B.A., Gual-Bonilla L., Sijapati K., Daniel R.A., Landry C.F., and Kelley A.E. Activation of a subpopulation of orexin/hypocretin-containing hypothalamic neurons by GABAA receptor-mediated inhibition of the nucleus accumbens shell, but not by exposure to a novel environment. European Journal of Neuroscience 19 2 (2004) 376-386
6. Baptista T., Parada M.A., and Hernandez L. Long-term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?. Pharmacology, Biochemistry and Behavior 27 3 (1987) 399-405
7. Baptista T., Kin N.M., Beaulieu S., and de Baptista E.A. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry 35 6 (2002) 205-219
8. Beart P.M., McDonald D., and Gundlach A.L. Mesolimbic dopaminergic neurones and somatodendritic mechanisms. Neuroscience Letters 15 2-3 (1979) 165-170
9. Bernstein J.G. Psychotropic drug induced weight gain: mechanisms and management. Clinical Neuropharmacology 11 1 (1988) S194-206
10. Bianchetti G., Zarifian E., Poirier-Littre M.F., Morselli P.L., and Deniker P. Influence of route of administration on haloperidol plasma levels in psychotic patients. International Journal of Clinical Pharmacology, Therapy and Toxicology 18 7 (1980) 324-327
11. Bird E.D., Spokes E.G., Barnes J., MacKay A.V., Iversen L.L., and Shepherd M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. The Lancet 2 8049 (1977) 1157-1158
12. Brown K.S., Gentry R.M., and Rowland N.E. Central injection in rats of α-melanocyte-stimulating hormone analog: effects on food intake and brain fos. Regulatory Peptides 78 1-3 (1998) 89-94
13. Christensen A.V., Arnt J., Hyttel J., Larsen J.J., and Svendsen O. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sciences 34 16 (1984) 1529-1540
14. Chu T.F., and Lin M.T. Picrotoxin induces both hypertension and dopamine release in the rat amygdala. Neuroscience Letters 218 3 (1996) 169-172
15. Cousins M.S., and Salamone J.D. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacology, Biochemistry and Behavior 49 1 (1994) 85-91
16. Cressman W.A., Bianchine J.R., Slotnick V.B., Johnson P.C., and Plostnieks J. Plasma level profile of haloperidol in man following intramuscular administration. European Journal of Clinical Pharmacology 7 (1974) 99-103
17. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., and Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 5 (2008) 1127-1136
18. de Belleroche J., and Gardiner I.M. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum. Journal of Neural Transmission 58 3-4 (1983) 153-168
19. Delle Donne K.T., Chan J., Boudin H., Pélaprat D., Rostène W., and Pickel V.M. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell. Synapse 52 3 (2004) 176-187
20. Dijk S., Krugers H.J., and Korf J. The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography. Neuropharmacology 30 5 (1991) 469-473
21. Doss F.W. The effects of antipsychotic drugs on body weight: a retrospective review. Journal of Clinical Psychiatry 40 12 (1979) 528-530
22. Ezrin-Waters C., and Seeman P. Tolerance of haloperidol catalepsy. European Journal of Pharmacology 41 3 (1977) 321-327
23. Fendt M., Schwienbacher I., and Koch M. Amygdaloid N-methyl-d-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats. Neuroscience 98 1 (2000) 55-60
24. Goyal S.N., Kokare D.M., Chopde C.T., and Subhedar N.K. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test. Pharmacology, Biochemistry and Behavior 85 (2006) 369-377
25. Graybiel A.M., Besson M.J., and Weber E. Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat. Journal of Neuroscience 9 1 (1989) 326-338
26. Hartfield A.W., Moore N.A., and Clifton P.G. Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat. Psychopharmacology (Berl) 167 2 (2003) 115-122
27. Hjelmstad G.O. Dopamine excites nucleus accumbens neurons through the differential modulation of glutamate and GABA release. Journal of Neuroscience 24 39 (2004) 8621-8628
28. Hu X.T., and Wang R.Y. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment. Brain Research 8 486 (1989) 325-333
29. Kaneko M., Sato K., Horikoshi R., Yaginuma M., Yaginuma N., Shiragata M., and Kumashiro H. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo. Prostaglandins, Leukotrienes and Essential Fatty Acids 46 1 (1992) 53-57
30. Kapetanovic I.M., Sweeney D.J., and Rapoport S.I. Age effects on haloperidol pharmacokinetics in male, Fischer-344 rats. Pharmacology and Experimental Therapeutics 221 2 (1982) 434-438
31. Kapur S., Barsoum S.C., and Seeman P. Dopamine D(2) receptor blockade by haloperidol: (3)H-raclopride reveals much higher occupancy than EEDQ. Neuropsychopharmacology 23 5 (2000) 595-598
32. Kaur G., and Kulkarni S.K. Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 26 2 (2002) 277-285
33. Kokare D.M., Dandekar M.P., Chopde C.T., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Research 1043 1-2 (2005) 107-114
34. A receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 50 1 (2006) 16-24
35. Korpi E.R., Wong G., and Lüddens H. Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine. Naunyn-Schmiedeberg's Archives of Pharmacology 352 4 (1995) 365-373
36. Kovalev G.I., and Hetey L. Regulation of 3H-dopamine release by presynaptic GABA and glutamate heteroreceptors in the synaptosomes of the rat nucleus accumbens. Biulleten Eksperimentalnoi Biologii i Medistsiny 103 1 (1987) 75-78
37. Le Moine C., and Bloch B. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience 73 1 (1996) 131-143
38. Lee M.D., and Clifton P.G. Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacology, Biochemistry and Behavior 71 1-2 (2002) 147-154
39. Ma J., Ye N., Lange N., and Cohen B.M. Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus. Neuroscience 121 4 (2003) 991-998
40. Mackay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., Creese I., and Synder S.H. Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry 39 9 (1982) 991-997
41. Mao C.C., Marco E., Revuelta A., Bertilsson L., and Costa E. The turnover rate of gamma-aminobutyric acid in the nuclei of telencephalon: implications in the pharmacology of antipsychotics and of a minor tranquilizer. Biological Psychiatry 12 3 (1977) 359-371
42. McLeod M.C., Sundram S., and Dean B. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32 2 (2008) 560-567
43. Minet-Ringuet J., Even P.C., Goubern M., Tomé D., and de Beaurepaire R. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration. Appetite 46 3 (2006) 254-262
44. Murai T., Koshikawa N., Kanayama T., Takada K., Tomiyama K., and Kobayashi M. Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. European Journal of Pharmacology 261 1-2 (1994) 65-71
45. Naruse T. Effects of repeated intravenous administration of diazepam on food intake in rats. Fundamental and Clinical Pharmacology 8 4 (1994) 379-384
46. Nowend K.L., Arizzi M., Carlson B.B., and Salamone J.D. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacology, Biochemistry and Behavior 69 3-4 (2001) 373-382
47. Obuchowicz E. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus. Neuropeptides 30 5 (1996) 471-478
48. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, London
49. Pecina S., and Berridge K.C. Brainstem mediates enhancement of palatability and feeding: Microinjections into fourth ventricle versus lateral ventricle. Brain Research 727 1-2 (1996) 22-30
50. Perez-Iglesias R., Vazquez-Barquero J.L., Amado J.A., Berja A., Garcia-Unzueta M.T., Pelayo-Terán J.M., Carrasco-Marín E., Mata I., and Crespo-Facorro B. Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment. Journal of Clinical Psychopharmacology 28 3 (2008) 289-295
51. Perry T.L., Kish S.J., Buchanan J., and Hansen S. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients. The Lancet 1 8110 (1979) 237-239
52. Pickel V.M., Joh T.H., and Chan J. Substance P in the rat nucleus accumbens: ultrastructural localization in axon terminals and their relation to dopaminergic afferents. Brain Research 444 2 (1988) 247-264
53. Rasmussen K., Hsu M.A., Noone S., Johnson B.G., Thompson L.K., and Hemrick-Luecke S.K. The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms. Schizophrenia Bulletin 33 6 (2007) 1291-1297
54. Reynolds S.M., and Berridge K.C. Fear and feeding in the nucleus accumbens shell: rostrocaudal segregation of GABA-elicited defensive behavior versus eating behavior. Journal of Neuroscience 1 21 (2001) 3261-3270
55. Sands S.A., de Blas A.L., and Chronwall B.M. Dopamine D2 receptor effects on GABA(A) receptor expression may modify melanotrope peptide release. Peptides 19 2 (1998) 397-401
56. Schleimer S.B., Johnston G.A., and Henderson J.M. Novel oral drug administration in an animal model of neuroleptic therapy. Journal of Neuroscience Methods 146 2 (2005) 159-164
57. Shimizu H., and Bray G.A. Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Research 621 2 (1993) 200-206
58. Soderpalm A.H., and Berridge K.C. Food intake after diazepam, morphine or muscimol: microinjections in the nucleus accumbens shell. Pharmacology, Biochemistry and Behavior 66 2 (2000) 429-434
59. Stanton J.M. Weight gain associated with neuroleptic medication: a review. Schizophrenia Bulletin 21 3 (1995) 463-512
60. Stratford T.R. Activation of feeding-related neural circuitry after unilateral injections of muscimol into the nucleus accumbens shell. Brain Research 1048 1-2 (2005) 241-250
61. Stratford T.R., and Kelley A.E. GABA in the nucleus accumbens shell participates in the central regulation of feeding behavior. Journal of Neuroscience 17 11 (1997) 4434-4440
62. Stratford T.R., and Kelley A.E. Evidence of a functional relationship between the nucleus accumbens shell and lateral hypothalamus subserving the control of feeding behavior. Journal of Neuroscience 19 24 (1999) 11040-11048
63. Stratford T.R., and Wirtshafter D. NPY mediates the feeding elicited by muscimol injections into the nucleus accumbens shell. NeuroReport 15 17 (2004) 2673-2676
64. Thompson T.L., and Moss R.L. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neuroscience Letters 229 3 (1997) 145-148
65. Wardas J., Ossowska K., and Wolfarth S. Evidence for the independent role of GABA synapses of the zona incerta-lateral hypothalamic region in haloperidol-induced catalepsy. Brain Research 462 2 (1988) 378-382
66. Wingkar K.C. Alterations in feeding and sexual behaviour during reproductive cycle in female rats. Indian Journal of Physiology and Pharmacology 36 3 (1992) 174-176
67. Wong A.C., Shetreat M.E., Clarke J.O., and Rayport S. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 89 1 (1999) 221-233
68. Zheng H., Corkern M., Stoyanova I., Patterson L.M., Tian R., and Berthoud H.R. Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 284 6 (2003) R1375
69. A receptor biding and GAD67 expression. Schizophrenia Research 66 2-3 (2004) 151-157
70. Znamensky V., Echo J.A., Lamonte N., Christian G., Ragnauth A., and Bodnar R.J. Gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats. Brain Research 906 1-2 (2001) 84-91